Innovative Industrial Properties (IIPR Quick QuoteIIPR - Free Report) is a REIT that specializes in buying properties for medical use cannabis and leasing them back. As of Feb 8, 2019, the company owned 12 properties which were 100% leased. Earnings are expected to rise 144% in 2019. As a REIT, it distributes 90% of its income to shareholders. The current dividend yield is 2.1%. Innovative Industrial Properties is a Zacks Rank #2 (Buy).

GW Pharmaceuticals plc is a British cannabinoid company making prescription medicines from cannabis. On Nov 1, it launched Epidiolex, the first and only FDA-approved plant-derived cannabinoid medicine for the treatment of difficult-to-treat forms of childhood-onset epilepsy.

Some analysts believe revenue could rise to $500 million from just $15 million over the next two years. This Zacks Rank #2 (Buy) will report earnings on Feb 26, 2019.

Should these two companies be on your investing short list? Find out in this week’s video.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>